Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| canSAR: update to the cancer translational research and drug discovery knowledgebase. | Nucleic Acids Res | 2023 | 36624665 | PubTator, text mining | PubMed |
| LINC00669 promotes lung adenocarcinoma growth by stimulating the Wnt/β-catenin signaling pathway. | Cancer Med | 2023 | 36621836 | PubTator, text mining | PubMed |
| CNTNAP4 signaling regulates osteosarcoma disease progression. | NPJ Precis Oncol | 2023 | 36599925 | PubTator, text mining | PubMed |
| Kinesin family member 3A induces related diseases via wingless-related integration site/β-catenin signaling pathway. | Sci Prog | 2023 | 36594221 | PubTator, text mining | PubMed |
| Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome. | Mol Oncol | 2023 | 36520032 | PubTator, text mining | PubMed |
| c-Src activation as a potential marker of chemical-induced skin irritation using tissue-engineered skin equivalents. | Exp Dermatol | 2023 | 36457227 | PubTator, text mining | PubMed |
| Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer's disease? | Neural Regen Res | 2023 | 36453396 | PubTator, text mining | PubMed |
| GSK3α phosphorylates dynamin-2 to promote GLUT4 endocytosis in muscle cells. | J Cell Biol | 2023 | 36445308 | PubTator, text mining | PubMed |
| Neuroprotective and anticancer effects of 7‑Methoxyheptaphylline via the TAK1 pathway. | Oncol Rep | 2023 | 36416312 | PubTator, text mining | PubMed |
| ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma. | Life Sci Alliance | 2023 | 36414381 | PubTator, text mining | PubMed |
| Cell-scaffold interactions in tissue engineering for oral and craniofacial reconstruction. | Bioact Mater | 2023 | 36406245 | PubTator, text mining | PubMed |
| VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia. | Leukemia | 2023 | 36376377 | PubTator, text mining | PubMed |
| FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelial‒Mesenchymal Transition. | J Invest Dermatol | 2023 | 36368445 | PubTator, text mining | PubMed |
| The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistance. | Cytokine | 2023 | 36327541 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Role of the Glycogen Synthase Kinase 3-Cyclic AMP/Protein Kinase A in the Immobilization of Human Sperm by Tideglusib. | Reprod Sci | 2023 | 36207578 | PubTator, text mining | PubMed |
| Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling. | Cancer Med | 2023 | 36047666 | PubTator, text mining | PubMed |
| Glycogen Synthase Kinase-3 Isoform Variants and Their Inhibitory Phosphorylation in Human Testes and Spermatozoa. | World J Mens Health | 2023 | 36047078 | PubTator, text mining | PubMed |
| Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation. | Cell Cycle | 2023 | 36005738 | PubTator, text mining | PubMed |
| Dysfunctional gene splicing in glucose metabolism may contribute to Alzheimer's disease. | Chin Med J (Engl) | 2023 | 35830275 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=15